HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors

Pheochromocytomas and paragangliomas are rare, neural crest‐originating, neuroendocrine tumors. HuR is an mRNA‐binding protein of the ELAV/Hu‐protein family, which participates in posttranscriptional regulation of many cancer‐associated genes. HuR expression has been connected with aggressive behavi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:APMIS : acta pathologica, microbiologica et immunologica Scandinavica microbiologica et immunologica Scandinavica, 2016-09, Vol.124 (9), p.757-763
Hauptverfasser: Leijon, Helena, Salmenkivi, Kaisa, Heiskanen, Ilkka, Hagström, Jaana, Louhimo, Johanna, Heikkilä, Päivi, Ristimäki, Ari, Paavonen, Timo, Metso, Saara, Mäenpää, Hanna, Haglund, Caj, Arola, Johanna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 763
container_issue 9
container_start_page 757
container_title APMIS : acta pathologica, microbiologica et immunologica Scandinavica
container_volume 124
creator Leijon, Helena
Salmenkivi, Kaisa
Heiskanen, Ilkka
Hagström, Jaana
Louhimo, Johanna
Heikkilä, Päivi
Ristimäki, Ari
Paavonen, Timo
Metso, Saara
Mäenpää, Hanna
Haglund, Caj
Arola, Johanna
description Pheochromocytomas and paragangliomas are rare, neural crest‐originating, neuroendocrine tumors. HuR is an mRNA‐binding protein of the ELAV/Hu‐protein family, which participates in posttranscriptional regulation of many cancer‐associated genes. HuR expression has been connected with aggressive behavior of several malignancies. Cyclooxygenase‐2 (COX‐2) is also expressed in several malignant tumors, and its expression is regulated by HuR. Tissue microarray of 153 primary pheochromocytomas and paragangliomas was investigated for the expression of HuR and COX‐2 proteins by immunohistochemistry using two different HuR antibodies (HuR19F12 and HuR3A). In these tumors, the expression of both intranuclear and cytoplasmic HuR was detectable. Increased cytoplasmic HuR expression was significantly associated with metastatic tumors. Increased COX‐2 and MIB‐1 expression also was associated with metastatic potential, and moreover, HuR and COX‐2 expression correlated with each other. Our data suggest that increased expression of HuR protein is associated with metastatic potential of paragangliomas and pheochromocytomas, and COX‐2 seems to be a target of HuR.
doi_str_mv 10.1111/apm.12571
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1815695185</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1813629039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4941-3bb005fd1d320f6f4ff0633b3a458549d0ad6274826d04d9f4dbcb035977e2da3</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxS0EotuFA18AReJCD2nH_5NjW2CLaAtCIMTJcmJ765LEwU6g--3xdtsekJCYy0ij33vSvIfQCwyHOM-RHvtDTLjEj9ACC4ASmKCP0QJqoCUTDO-h_ZSuATCphHyK9oikXBJRLdD3s_lz4YdivLKhvYqhD-1mCr1OhR5MMeqo13pYd_72VBbhl432Zow2JR-GrTAfvPPWFL3u_HrQw1RMcx9ieoaeON0l-_xuL9HXd2-_nJ6V5x9X70-Pz8uW1QyXtGkAuDPYUAJOOOYcCEobqhmvOKsNaCOIZBURBpipHTNN2wDltZSWGE2X6PXOd4zh52zTpHqfWtt1erBhTgpXmIua44r_D0oFyaHVGX31F3od5jjkR7YUqRjIHOISHeyoNoaUonVqjL7XcaMwqG01KlejbqvJ7Ms7x7nprXkg77vIwNEO-O07u_m3kzr-dHFvWe4UPk325kGh4w8lJJVcfbtcqQ8X-anVm0t1Qv8AsGOmSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1812840727</pqid></control><display><type>article</type><title>HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Leijon, Helena ; Salmenkivi, Kaisa ; Heiskanen, Ilkka ; Hagström, Jaana ; Louhimo, Johanna ; Heikkilä, Päivi ; Ristimäki, Ari ; Paavonen, Timo ; Metso, Saara ; Mäenpää, Hanna ; Haglund, Caj ; Arola, Johanna</creator><creatorcontrib>Leijon, Helena ; Salmenkivi, Kaisa ; Heiskanen, Ilkka ; Hagström, Jaana ; Louhimo, Johanna ; Heikkilä, Päivi ; Ristimäki, Ari ; Paavonen, Timo ; Metso, Saara ; Mäenpää, Hanna ; Haglund, Caj ; Arola, Johanna</creatorcontrib><description>Pheochromocytomas and paragangliomas are rare, neural crest‐originating, neuroendocrine tumors. HuR is an mRNA‐binding protein of the ELAV/Hu‐protein family, which participates in posttranscriptional regulation of many cancer‐associated genes. HuR expression has been connected with aggressive behavior of several malignancies. Cyclooxygenase‐2 (COX‐2) is also expressed in several malignant tumors, and its expression is regulated by HuR. Tissue microarray of 153 primary pheochromocytomas and paragangliomas was investigated for the expression of HuR and COX‐2 proteins by immunohistochemistry using two different HuR antibodies (HuR19F12 and HuR3A). In these tumors, the expression of both intranuclear and cytoplasmic HuR was detectable. Increased cytoplasmic HuR expression was significantly associated with metastatic tumors. Increased COX‐2 and MIB‐1 expression also was associated with metastatic potential, and moreover, HuR and COX‐2 expression correlated with each other. Our data suggest that increased expression of HuR protein is associated with metastatic potential of paragangliomas and pheochromocytomas, and COX‐2 seems to be a target of HuR.</description><identifier>ISSN: 0903-4641</identifier><identifier>EISSN: 1600-0463</identifier><identifier>DOI: 10.1111/apm.12571</identifier><identifier>PMID: 27357268</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Cell Nucleus - chemistry ; Cyclooxygenase 2 - analysis ; Cytoplasm - chemistry ; ELAV-Like Protein 1 - analysis ; Gene Expression ; Gene Expression Profiling ; Humans ; HuR ; Immunohistochemistry ; Metastasis ; Microarray Analysis ; Neoplasm Metastasis - pathology ; paraganglioma ; Paraganglioma - pathology ; Paraganglioma - secondary ; pheochromocytoma ; Pheochromocytoma - pathology ; Pheochromocytoma - secondary ; Proteins ; Tumors</subject><ispartof>APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2016-09, Vol.124 (9), p.757-763</ispartof><rights>2016 APMIS. Published by John Wiley &amp; Sons Ltd</rights><rights>2016 APMIS. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2016 APMIS Published by John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4941-3bb005fd1d320f6f4ff0633b3a458549d0ad6274826d04d9f4dbcb035977e2da3</citedby><cites>FETCH-LOGICAL-c4941-3bb005fd1d320f6f4ff0633b3a458549d0ad6274826d04d9f4dbcb035977e2da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapm.12571$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapm.12571$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27357268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leijon, Helena</creatorcontrib><creatorcontrib>Salmenkivi, Kaisa</creatorcontrib><creatorcontrib>Heiskanen, Ilkka</creatorcontrib><creatorcontrib>Hagström, Jaana</creatorcontrib><creatorcontrib>Louhimo, Johanna</creatorcontrib><creatorcontrib>Heikkilä, Päivi</creatorcontrib><creatorcontrib>Ristimäki, Ari</creatorcontrib><creatorcontrib>Paavonen, Timo</creatorcontrib><creatorcontrib>Metso, Saara</creatorcontrib><creatorcontrib>Mäenpää, Hanna</creatorcontrib><creatorcontrib>Haglund, Caj</creatorcontrib><creatorcontrib>Arola, Johanna</creatorcontrib><title>HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors</title><title>APMIS : acta pathologica, microbiologica et immunologica Scandinavica</title><addtitle>APMIS</addtitle><description>Pheochromocytomas and paragangliomas are rare, neural crest‐originating, neuroendocrine tumors. HuR is an mRNA‐binding protein of the ELAV/Hu‐protein family, which participates in posttranscriptional regulation of many cancer‐associated genes. HuR expression has been connected with aggressive behavior of several malignancies. Cyclooxygenase‐2 (COX‐2) is also expressed in several malignant tumors, and its expression is regulated by HuR. Tissue microarray of 153 primary pheochromocytomas and paragangliomas was investigated for the expression of HuR and COX‐2 proteins by immunohistochemistry using two different HuR antibodies (HuR19F12 and HuR3A). In these tumors, the expression of both intranuclear and cytoplasmic HuR was detectable. Increased cytoplasmic HuR expression was significantly associated with metastatic tumors. Increased COX‐2 and MIB‐1 expression also was associated with metastatic potential, and moreover, HuR and COX‐2 expression correlated with each other. Our data suggest that increased expression of HuR protein is associated with metastatic potential of paragangliomas and pheochromocytomas, and COX‐2 seems to be a target of HuR.</description><subject>Cell Nucleus - chemistry</subject><subject>Cyclooxygenase 2 - analysis</subject><subject>Cytoplasm - chemistry</subject><subject>ELAV-Like Protein 1 - analysis</subject><subject>Gene Expression</subject><subject>Gene Expression Profiling</subject><subject>Humans</subject><subject>HuR</subject><subject>Immunohistochemistry</subject><subject>Metastasis</subject><subject>Microarray Analysis</subject><subject>Neoplasm Metastasis - pathology</subject><subject>paraganglioma</subject><subject>Paraganglioma - pathology</subject><subject>Paraganglioma - secondary</subject><subject>pheochromocytoma</subject><subject>Pheochromocytoma - pathology</subject><subject>Pheochromocytoma - secondary</subject><subject>Proteins</subject><subject>Tumors</subject><issn>0903-4641</issn><issn>1600-0463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9v1DAQxS0EotuFA18AReJCD2nH_5NjW2CLaAtCIMTJcmJ765LEwU6g--3xdtsekJCYy0ij33vSvIfQCwyHOM-RHvtDTLjEj9ACC4ASmKCP0QJqoCUTDO-h_ZSuATCphHyK9oikXBJRLdD3s_lz4YdivLKhvYqhD-1mCr1OhR5MMeqo13pYd_72VBbhl432Zow2JR-GrTAfvPPWFL3u_HrQw1RMcx9ieoaeON0l-_xuL9HXd2-_nJ6V5x9X70-Pz8uW1QyXtGkAuDPYUAJOOOYcCEobqhmvOKsNaCOIZBURBpipHTNN2wDltZSWGE2X6PXOd4zh52zTpHqfWtt1erBhTgpXmIua44r_D0oFyaHVGX31F3od5jjkR7YUqRjIHOISHeyoNoaUonVqjL7XcaMwqG01KlejbqvJ7Ms7x7nprXkg77vIwNEO-O07u_m3kzr-dHFvWe4UPk325kGh4w8lJJVcfbtcqQ8X-anVm0t1Qv8AsGOmSw</recordid><startdate>201609</startdate><enddate>201609</enddate><creator>Leijon, Helena</creator><creator>Salmenkivi, Kaisa</creator><creator>Heiskanen, Ilkka</creator><creator>Hagström, Jaana</creator><creator>Louhimo, Johanna</creator><creator>Heikkilä, Päivi</creator><creator>Ristimäki, Ari</creator><creator>Paavonen, Timo</creator><creator>Metso, Saara</creator><creator>Mäenpää, Hanna</creator><creator>Haglund, Caj</creator><creator>Arola, Johanna</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201609</creationdate><title>HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors</title><author>Leijon, Helena ; Salmenkivi, Kaisa ; Heiskanen, Ilkka ; Hagström, Jaana ; Louhimo, Johanna ; Heikkilä, Päivi ; Ristimäki, Ari ; Paavonen, Timo ; Metso, Saara ; Mäenpää, Hanna ; Haglund, Caj ; Arola, Johanna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4941-3bb005fd1d320f6f4ff0633b3a458549d0ad6274826d04d9f4dbcb035977e2da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cell Nucleus - chemistry</topic><topic>Cyclooxygenase 2 - analysis</topic><topic>Cytoplasm - chemistry</topic><topic>ELAV-Like Protein 1 - analysis</topic><topic>Gene Expression</topic><topic>Gene Expression Profiling</topic><topic>Humans</topic><topic>HuR</topic><topic>Immunohistochemistry</topic><topic>Metastasis</topic><topic>Microarray Analysis</topic><topic>Neoplasm Metastasis - pathology</topic><topic>paraganglioma</topic><topic>Paraganglioma - pathology</topic><topic>Paraganglioma - secondary</topic><topic>pheochromocytoma</topic><topic>Pheochromocytoma - pathology</topic><topic>Pheochromocytoma - secondary</topic><topic>Proteins</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leijon, Helena</creatorcontrib><creatorcontrib>Salmenkivi, Kaisa</creatorcontrib><creatorcontrib>Heiskanen, Ilkka</creatorcontrib><creatorcontrib>Hagström, Jaana</creatorcontrib><creatorcontrib>Louhimo, Johanna</creatorcontrib><creatorcontrib>Heikkilä, Päivi</creatorcontrib><creatorcontrib>Ristimäki, Ari</creatorcontrib><creatorcontrib>Paavonen, Timo</creatorcontrib><creatorcontrib>Metso, Saara</creatorcontrib><creatorcontrib>Mäenpää, Hanna</creatorcontrib><creatorcontrib>Haglund, Caj</creatorcontrib><creatorcontrib>Arola, Johanna</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>APMIS : acta pathologica, microbiologica et immunologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leijon, Helena</au><au>Salmenkivi, Kaisa</au><au>Heiskanen, Ilkka</au><au>Hagström, Jaana</au><au>Louhimo, Johanna</au><au>Heikkilä, Päivi</au><au>Ristimäki, Ari</au><au>Paavonen, Timo</au><au>Metso, Saara</au><au>Mäenpää, Hanna</au><au>Haglund, Caj</au><au>Arola, Johanna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors</atitle><jtitle>APMIS : acta pathologica, microbiologica et immunologica Scandinavica</jtitle><addtitle>APMIS</addtitle><date>2016-09</date><risdate>2016</risdate><volume>124</volume><issue>9</issue><spage>757</spage><epage>763</epage><pages>757-763</pages><issn>0903-4641</issn><eissn>1600-0463</eissn><abstract>Pheochromocytomas and paragangliomas are rare, neural crest‐originating, neuroendocrine tumors. HuR is an mRNA‐binding protein of the ELAV/Hu‐protein family, which participates in posttranscriptional regulation of many cancer‐associated genes. HuR expression has been connected with aggressive behavior of several malignancies. Cyclooxygenase‐2 (COX‐2) is also expressed in several malignant tumors, and its expression is regulated by HuR. Tissue microarray of 153 primary pheochromocytomas and paragangliomas was investigated for the expression of HuR and COX‐2 proteins by immunohistochemistry using two different HuR antibodies (HuR19F12 and HuR3A). In these tumors, the expression of both intranuclear and cytoplasmic HuR was detectable. Increased cytoplasmic HuR expression was significantly associated with metastatic tumors. Increased COX‐2 and MIB‐1 expression also was associated with metastatic potential, and moreover, HuR and COX‐2 expression correlated with each other. Our data suggest that increased expression of HuR protein is associated with metastatic potential of paragangliomas and pheochromocytomas, and COX‐2 seems to be a target of HuR.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>27357268</pmid><doi>10.1111/apm.12571</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0903-4641
ispartof APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2016-09, Vol.124 (9), p.757-763
issn 0903-4641
1600-0463
language eng
recordid cdi_proquest_miscellaneous_1815695185
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Cell Nucleus - chemistry
Cyclooxygenase 2 - analysis
Cytoplasm - chemistry
ELAV-Like Protein 1 - analysis
Gene Expression
Gene Expression Profiling
Humans
HuR
Immunohistochemistry
Metastasis
Microarray Analysis
Neoplasm Metastasis - pathology
paraganglioma
Paraganglioma - pathology
Paraganglioma - secondary
pheochromocytoma
Pheochromocytoma - pathology
Pheochromocytoma - secondary
Proteins
Tumors
title HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T19%3A28%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HuR%20in%20pheochromocytomas%20and%20paragangliomas%20-%20overexpression%20in%20verified%20malignant%20tumors&rft.jtitle=APMIS%20:%20acta%20pathologica,%20microbiologica%20et%20immunologica%20Scandinavica&rft.au=Leijon,%20Helena&rft.date=2016-09&rft.volume=124&rft.issue=9&rft.spage=757&rft.epage=763&rft.pages=757-763&rft.issn=0903-4641&rft.eissn=1600-0463&rft_id=info:doi/10.1111/apm.12571&rft_dat=%3Cproquest_cross%3E1813629039%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1812840727&rft_id=info:pmid/27357268&rfr_iscdi=true